Consensus Microbot Medical Inc.

Equities

MBOT

US59503A2042

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-31 pm EDT			5-day change	1st Jan Change
1 ^USD	-.--%		-1.96%	-39.02%

May. 15	Microbot Medical Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Apr. 29	Microbot Medical Announces Positive Results from the First Phase of Its Collaboration with Corewell Health	CI

Evolution of the average Target Price on Microbot Medical Inc.

Price target over the last 5 years

History of analyst recommendation changes

01e00a5282dffc9238dd30781f2cc95f.n79-xoqqL-3W3Q0eaX9bEq889v5BmpMt5yn-CvtUo_8.6vwH9tL-V4S8i15JBTYuW8pawJ0G3_d31HypUrM6yavKz0a08PNVpITqfg~76c25ff0dcded325cdffb2cdecb17ba4

Analyst Recommendations on Microbot Medical Inc.

HC Wainwright Adjusts Microbot Medical's Price Target to $7 From $8, Keeps Buy Rating	Apr. 16	MT
HC Wainwright Adjusts Price Target on Microbot Medical to $8 From $20, Keeps Buy Rating	23-05-09	MT

More recommendations

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

1 USD

Average target price

7 USD

Spread / Average Target

+600.00%

High Price Target

7 USD

Spread / Highest target

+600.00%

Low Price Target

7 USD

Spread / Lowest Target

+600.00%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Microbot Medical Inc.

HC Wainwright

Quarterly revenue - Rate of surprise

Company calendar